No political development may be more important for the biopharma sector in 2008 than the ascension of California Democrat Henry Waxman to Chairman of the Energy & Commerce Committee.
Waxman won a vote of the House Democratic Caucus to unseat longstanding Chairman John Dingell (D-Mich.) on November 20.






